Nicholas A. LaBella's Insider Trades & SAST Disclosures

Nicholas A. LaBella's most recent trade in ZyVersa Therapeutics Inc was a trade of 59,563 Stock Options (right to buy) done . Disclosure was reported to the exchange on Dec. 12, 2022.

Share

Note

This is a custom search result for pattern Nicholas A. LaBella.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
ZyVersa Therapeutics Inc	Nicholas A. LaBella	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Dec 2022	59,563	59,563	-		-	Stock Options (right to buy)
ZyVersa Therapeutics Inc	Nicholas A. LaBella	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Dec 2022	39,709	39,709	-		-	Stock Options (right to buy)
ZyVersa Therapeutics Inc	Nicholas A. LaBella	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Dec 2022	39,708	39,708	-		-	Stock Options (right to buy)
ZyVersa Therapeutics Inc	Nicholas A. LaBella	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Dec 2022	29,781	29,781	-		-	Stock Options (right to buy)
ZyVersa Therapeutics Inc	Nicholas A. LaBella	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Dec 2022	29,781	29,781	-		-	Stock Options (right to buy)
ZyVersa Therapeutics Inc	Nicholas A. LaBella	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Dec 2022	19,854	19,854	-		-	Stock Options (right to buy)
ZyVersa Therapeutics Inc	Nicholas A. LaBella	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Dec 2022	18,094	18,094	-		-	Common Stock
ZyVersa Therapeutics Inc	Nicholas A. LaBella	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Dec 2022	18,094	18,094	-		-	Warrant (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades